RecruitingType 2 DiabetesHeart Failure, Reduced Ejection Fraction
Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
Eligible age
18–80 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will provide insight into whether cardiac function changes with oral Ketone Esters (KE) administered to patients with Type 2 Diabetes Mellitus (T2DM) and Heart failure with reduced ejection fraction (HFrEF). Plasma ketones are avidly extracted by cardiac muscle and their uptake is not dependent upon insulin or influenced by insulin resistance.
Sponsor: The University of Texas Health Science Center at San Antonio
You may qualify if…
- ✓ Subjects must be on a stable dose of guideline-directed medications for Heart Failure (HF).
- ✓ Patients will have an established diagnosis of HF before the screening visit, documented by an acceptable imaging modality in the last 6 months.
- ✓ Age = 18-80 y
- ✓ Body Mass Index (BMI) =23-38 kg/m2
- ✓ Glycated hemoglobin (HbA1c) = 6.0-10.0%
- ✓ Blood Pressure (BP) \< 145/85 mmHg
- ✓ Estimated Glomerular Filtration Rate (eGFR) \> 30 ml/min•1.73 m2
- ✓ For women of child-bearing age (WOCBA) willingness to use contraception, if applicable.
You may not qualify if…
- ✕ Patients treated with Sodium-Glucose Transport Protein (SGLT2i's) or medications that may impair heart function or acutely worsen glycemic control will be excluded.
- ✕ Pregnancy, lactation, or plans to become pregnant. A negative pregnancy test will be performed before each Magnetic resonance imaging (MRI) study to assess current status.
- ✕ Allergy/sensitivity to study drugs or their ingredients.
- ✕ Current drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements.
- ✕ Inability or unwillingness of individual or legal guardian/representative to give written informed consent.
- ✕ Subjects with a history of cancer (except basal or squamous cell cancer that has been resolved/remission for 5 years)
- ✕ Cardiovascular event within the last 3 months
- ✕ Major organ or metabolic diseases, or physical limitations that will not allow the subject to complete the study.
Where it's recruiting
Texas
San Antonio
Source: ClinicalTrials.gov · NCT06108076 · last updated 2026-01-21